The number one nutrient to reduce insulin resistance is dietary fiber, primarily because of the way it helps slow digestion ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Nearly 16% of American adults -- that's close to 1 in 6 -- now has diabetes, according to the latest data from the U.S.

Lucrative weight loss drugs are new focus for diabetes patients The ... However, he noted, the market is changing. "The world ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Lucrative weight loss drugs are new focus for diabetes ... "The world market for insulin is actually declining, so there's less demand," said Jørgensen. He said he feared new drug companies ...

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential ... which are ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the ... patients increasingly turn to drugs such as Ozempic and Mounjaro ...

Adults with mild type 2 diabetes might improve their insulin sensitivity by following a low-carb diet, thus potentially ...